e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
CPAP therapy
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The reversibility of hypoxemia in OSA patients is related to CPAP therapy
A. E. Taurino, C. Bruschi, R. Trentin, N. D‘D‘Artavilla Lupo, S. Montemartini, F. Fanfulla (Montescano, Italy)
Source:
Annual Congress 2005 - CPAP therapy
Session:
CPAP therapy
Session type:
Thematic Poster Session
Number:
785
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. E. Taurino, C. Bruschi, R. Trentin, N. D‘D‘Artavilla Lupo, S. Montemartini, F. Fanfulla (Montescano, Italy). The reversibility of hypoxemia in OSA patients is related to CPAP therapy. Eur Respir J 2005; 26: Suppl. 49, 785
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Clinical case discussion: ERS guidelines on high flow nasal cannula in acute respiratory failure: from the clinical cases to the scientific evidence
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
Related content which might interest you:
The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018
Automatic bi-level positive airway pressure therapy in non compliant CPAP patients with obstructive sleep apnoea
Source: Annual Congress 2007 - Sleep apnoea and adaptive servo–ventilation
Year: 2007
Compliance for NIMV treatment in moderate and severe OSAS patients
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012
Persistent daytime hypercapnia predicts poor prognosis in OSAS undergoing CPAP therapy
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016
The effect of CPAP in asthma patients with SAHS
Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes
Year: 2021
Efficacy of continuous positive airway pressure in treatment of patients with bradyarrhythmias associated with obstructive sleep apnoea syndrome
Source: Annual Congress 2006 - Cardiovascular consequences of obstructive sleep apnoea
Year: 2006
Compliance of positive airway pressure therapy in patients with sleep related breathing disorder
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008
CPAP setting prediction in OSAS patients
Source: Annual Congress 2011 - Physiology and diagnostic technology in obstructive sleep apnoea
Year: 2011
Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years
Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea
Year: 2006
Predictors of compliance with CPAP in patients with OSA and metabolic syndrome
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009
Eficacy of the treatment with CPAP in patients with chronic heart failure and sleep apnoea
Source: Eur Respir J 2004; 24: Suppl. 48, 564s
Year: 2004
Daytime risk factors of nocturnal hyoxemia in COPD patients unqualified for long-term oxygen therapy
Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Year: 2012
Hypercapnia and respiratory drive in obstructive sleep apnoea patients before and after CPAP treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 103s
Year: 2002
Long-term outcome of nCPAP therapy in sleep apnoea patients
Source: Eur Respir J 2004; 24: Suppl. 48, 569s
Year: 2004
CPAP treatment reduce blood pressure in patients with recent diagnosis of systemic hypertension and obstructive sleep apnoea -hypopnoea (OSAH). A controlled study
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008
Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009
A study of insulin resistance in moderate to severe obstructive sleep apnea in non diabetics and its response to nasal CPAP treatment
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011
The effect of CPAP treatment on Galectin-3 level in patients with severe obstructive sleep apnea
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018
Effect of treatment with CPAP in patients with resistant hypertension and obstructive apneas
Source: Eur Respir J 2005; 26: Suppl. 49, 113s
Year: 2005
Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept